Ireland
--:--IST
Recruiting Phase 4

Socket Preservation Using Biodentin Versus Xeno Graft for Single Rooted Teeth

NCT06695208 · tracked via the Priya Life Science Egypt tracker
Phase
Phase 4
Started
2024-12-01
Last updated
2024-11-19

Condition(s) studied

Socket Perservation

Investigational drug(s) / intervention(s)

Biodentine →

Biodentine: biodentine used in socket preservation

Study summary

socket preservation using biodentin versus xeno graft for single rooted mandibular teeth

Eligibility

Sex
ALL
Min age
25 Years
Max age
50 Years
Healthy volunteers
No
Inclusion Criteria: * Patients of both sex with badly decayed tooth indicated for extraction * The ages of the patients ranged from 25 to 50 years. * Patients with healthy systemic condition (Medically free) * Adequate inter-arch space for placement of the implant prosthetic part. * Good oral hygiene * Cooperative patients who are willing to commit for 6 months follow up Exclusion Criteria: * Subjected to irradiation in the head and neck area less than 1 year before implantation. * Poor oral hygiene and motivation. * Smokers * Patient with medical condition that contraindicates surgical procedures * Pregnant or nursing. * Substance abuse. * Patients with habits that may jeopardize the implant longevity and affect the results of the study such as alcoholism or parafunctional habits severe bruxism or clenching. * Active infection or severe inflammation in the area intended for implant placement. * Patients on medication that may interfere with healing (corticosteroids, bisphosphonate, Chemo/radio therapy).

Primary outcome measure(s)

  • radiographic assessment to calculate bone width in millimeters after socket preservation in mandibular single rooted teeth using cone beam computed tomography — 6 months postoperative
    calculation of bone width gain in millimeters in extraction socket in mandibular single rooted teeth using cone beam computed tomography.

Trial sites (1)

FacilityCityRegionStatus
Cairo university Giza Egypt Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06695208 on ClinicalTrials.gov ↗ ← All trials in Egypt